CrossBridge Bio

CrossBridge Bio CrossBridge Bio is a Houston-based biotechnology company at the TMC|Accelerator program creating dual-payload Antibody-Drug Conjugates (ADCs) for cancer medication using Proprietary Linking Technology. This technology is designed to improve the potency and safety of cancer treatments, particularly in addressing tumor resistance and heterogeneity. In late 2023, their emerging company needed a brand and […]